{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T20:16:15Z","timestamp":1768162575815,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jfma.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T23:48:38Z","timestamp":1611704918000},"page":"1444-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-4327","authenticated-orcid":false,"given":"Grace Hui-Min","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoh-Fang","family":"Pwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Shinn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.01.005_bib1","series-title":"Global report on access to hepatitis C treatment: focus on overcoming barriers. Geneva","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jfma.2021.01.005_bib2","series-title":"Global health sectors strategy on viral hepatitis 2016\u20132021: towards ending viral hepatitis. Geneva","author":"World Health Organization","year":"2016"},{"issue":"12","key":"10.1016\/j.jfma.2021.01.005_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jfma.2018.10.021","article-title":"Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies","volume":"117","author":"Wu","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jfma.2021.01.005_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1473-3099(19)30170-7","article-title":"Taiwan commits to eliminating hepatitis C in 2025","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2021.01.005_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/liv.14412","article-title":"Taiwan is on track of accelerating hepatitis C elimination by 2025","volume":"40","author":"Wu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2021.01.005_bib6","series-title":"Taiwan hepatitis C policy guidelines 2018\u20132025. Taipei","author":"Ministry of Health and Welfare","year":"2019"},{"issue":"5","key":"10.1016\/j.jfma.2021.01.005_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4065\/71.5.458","article-title":"Hepatitis C genotypes: current trends and future implications","volume":"71","author":"Zein","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"1 Suppl","key":"10.1016\/j.jfma.2021.01.005_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.jfma.2021.01.005_bib10","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1073\/pnas.89.15.7144","article-title":"At least five related, but distinct, hepatitis C viral genotypes exist","volume":"89","author":"Cha","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 6","key":"10.1016\/j.jfma.2021.01.005_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1099\/0022-1317-78-6-1341","article-title":"Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East","volume":"78","author":"Chamberlain","year":"1997","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4269\/ajtmh.1998.59.571","article-title":"Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes","volume":"59","author":"Abdulkarim","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl B","key":"10.1016\/j.jfma.2021.01.005_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0149-2918(96)80193-7","article-title":"Virology of hepatitis C virus","volume":"18","author":"Simmonds","year":"1996","journal-title":"Clin Therapeut"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.2006.102558","article-title":"A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C","volume":"56","author":"Yu","year":"2007","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jfma.2021.01.005_bib15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/592579","article-title":"Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial","volume":"47","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2021.01.005_bib16","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.22319","article-title":"Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial","volume":"47","author":"Yu","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2021.01.005_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.jfma.2021.01.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350501000118","article-title":"Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes","volume":"10","author":"Hnatyszyn","year":"2005","journal-title":"Antivir Ther"},{"issue":"8959","key":"10.1016\/j.jfma.2021.01.005_bib19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(95)91993-7","article-title":"Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin","volume":"345","author":"Power","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jfma.2021.01.005_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2008.02.001","article-title":"Changing HCV genotypes distribution in Poland--relation to source and time of infection","volume":"42","author":"Chlabicz","year":"2008","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jmv.20828","article-title":"Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time","volume":"79","author":"Tallo","year":"2007","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.jfma.2021.01.005_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2893.2005.00649.x","article-title":"Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates","volume":"13","author":"Katsoulidou","year":"2006","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0168-8278(97)80411-4","article-title":"Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters","volume":"26","author":"Berg","year":"1997","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2021.01.005_bib24","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/infdis\/171.6.1607","article-title":"Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C","volume":"171","author":"Pawlotsky","year":"1995","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2021.01.005_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.38.2.269","article-title":"Hepatitis C virus: epidemiology and genotypes in the north east of England","volume":"38","author":"Watson","year":"1996","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jfma.2021.01.005_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijc.28753","article-title":"Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma","volume":"135","author":"Lee","year":"2014","journal-title":"Int J Canc"},{"issue":"1","key":"10.1016\/j.jfma.2021.01.005_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jmv.2001","article-title":"Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan","volume":"65","author":"Yu","year":"2001","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.jfma.2021.01.005_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1572-0241.2007.01181.x","article-title":"Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication","volume":"102","author":"Huang","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jfma.2021.01.005_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.trstmh.2005.10.008","article-title":"Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications","volume":"100","author":"Lee","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004836-199510000-00014","article-title":"Genotypes of hepatitis C virus in Taiwan and the progression of liver disease","volume":"21","author":"Kao","year":"1995","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jmv.1890440304","article-title":"Genotypes of hepatitis C virus in chronic liver disease in Taiwan","volume":"44","author":"Chen","year":"1994","journal-title":"J Med Virol"},{"issue":"15","key":"10.1016\/j.jfma.2021.01.005_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003284","article-title":"The hepatitis viral status in patients with hepatocellular carcinoma: a study of 3843 patients from Taiwan liver cancer network","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jfma.2021.01.005_bib33","series-title":"Study of incidence in hepatitis C and the community transmission routes and the following developing hepatic diseases in hepatitis C virus hyperendemic areas in southern Taiwan","author":"Chang","year":"2003"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094791","article-title":"Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection","volume":"9","author":"Hsieh","year":"2014","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.jfma.2021.01.005_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jfma.2021.01.005_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jmv.21658","article-title":"Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form_2b6w","volume":"82","author":"Lee","year":"2010","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.jfma.2021.01.005_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"Lond J Prim Care"},{"key":"10.1016\/j.jfma.2021.01.005_bib38","author":"Ministry of the Interior"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jmv.1890460314","article-title":"Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan","volume":"46","author":"Chen","year":"1995","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/(SICI)1096-9071(199708)52:4<370::AID-JMV4>3.0.CO;2-Z","article-title":"High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena?","volume":"52","author":"Ho","year":"1997","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.jfma.2021.01.005_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0895-4356(98)00060-2","article-title":"Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan","volume":"51","author":"Wang","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jfma.2021.01.005_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jmv.1097","article-title":"Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors","volume":"65","author":"Sun","year":"2001","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jfma.2021.01.005_bib43","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.addbeh.2013.01.010","article-title":"High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan","volume":"38","author":"Ng","year":"2013","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.jfma.2021.01.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194149","article-title":"Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan","volume":"13","author":"Li","year":"2018","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.jfma.2021.01.005_bib45","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/liv.14199","article-title":"HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan","volume":"39","author":"Huang","year":"2019","journal-title":"Liver Int"},{"issue":"1 Pt 3","key":"10.1016\/j.jfma.2021.01.005_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jfma.2019.07.021","article-title":"High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays","volume":"119","author":"Chen","year":"2020","journal-title":"J Formos Med Assoc"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462100022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462100022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:45:15Z","timestamp":1760539515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462100022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S092966462100022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}